close

Fundraisings and IPOs

1 2 3 4 5 60
Number of results: 1192
Date Company Amount Funding type Investors Therapeutic area Type of Information
2017-01-05 Therachon (France) $ 40 million series A financing round OrbiMed (USA - NY) New Enterprise Associates (NEA) (USA - MD) Inserm Transfert Initiative (ITI) (France) Versant Ventures (USA - CA) Bpifrance (France) Rare diseases - Genetic diseases Series A financing round
2017-01-03 Clovis Oncology (USA - CO) $175 million private placement Cancer - Oncology Private placement
2016-12-21 Oryzon Genomics (Spain) $ 0.8 million grant Ministry of Economy and Competitiveness, Government of Spain, FEDER Funds Inflammatory diseases Grant
2016-12-16 Soligenix (USA - NJ) $ 5.28 million private placement Rare diseases Private placement
2016-12-15 Valneva (France - Austria) €7.5 million private placement MVM Life Science Partners (UK) Infectious diseases - Veterinary medicine - Technology - Services Private placement
2016-12-13 CytRx Corporation (USA - CA) $7.4 million private placement existing institutional investors Cancer - Oncology Private placement
2016-12-12 BlueRock Therapeutics (USA - Canada) $ 225 million series A financing round Bayer Healthcare (Germany) Versant Ventures (USA - CA) Cardiovascular diseases - Neurodegenerative diseases Series A financing round
2016-12-12 Herantis Pharma (Finland) TreatER project € 6 million grant European Commission’s Horizon 2020 programme CNS diseases - Neurological diseases Grant
2016-12-05 Ixchelsis (UK) $ 12 million financing round TVM Life Science VII (Canada) Pfizer Venture Investments (USA - NY) Urological diseases Financing round
2016-12-02 Cerevance (USA - MA) $36 million series A financing round Takeda Pharmaceutical (Japan) Lightstone Ventures (USA - CA) CNS diseases - Mental diseases - Neurological diseases Series A financing round
2016-12-02 Amryt Pharma (Ireland) € 20 million loan European Investment Bank (EIB) Rare diseases Loan
2016-11-29 Cytune Pharma (France) € 6 million financing round PPF Group (Czech Republic) founding shareholders Cancer - Oncology - Infectious diseases Financing round
2016-11-22 Fate Therapeutics (USA - CA) $57 million private placement Cancer - Oncology - Immunological diseases Private placement
2016-11-10 Transgene (France) €46.4 million capital increase Institut Mérieux (France) Cancer - Oncology - Infectious diseases Capital increase
2016-11-04 Plasticell (UK) £1.32 million (€1.48 million) financing round Cancer - Oncology Fundraising
2016-11-03 NBE Therapeutics (Switzerland) CHF 20 million (€ 18.5 million) series B financing round PPF Group (Czech Republic) Boehringer Ingelheim Venture Fund (BIVF) (Germany) existing private investors and a new private investor Series B financing round
2016-10-25 eHealth Ventures (Israel) financing round Amgen (USA - CA) Maccabi Healthcare Services (Israel) Medison Pharma (Israel) Financing round
2016-10-18 Mavalon Therapeutics (UK) up to € 9 million financing round Medicxi Ventures (UK - Switzerland) Neurodegenerative diseases Financing round
2016-10-12 Immunomedics (USA - NJ) $30 million private placement Cancer - Oncology Private placement
2016-10-07 Newron Pharmaceuticals (Italy) CHF 26.1 million (€ 23.9 million) private placement CNS diseases Private placement